INS and polycystic ovary syndrome: Letrozole (LTZ) delivery in this trial caused a substantial rise in blood insulin levels (p 0.001) against healthy controls, and we also discovered a significant fall in insulin in the PCOS group receiving QUER in comparison to the PCOS group not receiving treatment (Figure 1).